Read Larry Connors' blog – Short Term Trading Strategies
Nackel succeeds Ted Chien, who led Ingenix Consulting successfully for four years. "John's deep industry and client-service experience combines with his visionary and innovative leadership to make him the right person to help Ingenix Consulting in our mission to deliver meaningful, transformative solutions to our clients' most important challenges," said Ingenix CEO Andy Slavitt. "The imperative to deliver better quality care, to more people and at lower cost has never been greater. With a background in health systems engineering and significant client-focused service, John will lead a team with the resources, expertise and capabilities to help health care organizations achieve breakthrough performance. John's focus on culture means we will continue to attract the brightest people in the industry." With over 30 years of experience advising health care organizations, entrepreneurs and emerging businesses, Nackel is one of the industry's foremost performance improvement experts. Most recently, Nackel was Chairman and CEO of Three-Sixty Advisory Group, LLC, a business he founded to help emerging health care services and medical technology companies accelerate their growth, efficiency and capital. Nackel also was the global managing director of Health Care Consulting at Ernst & Young. Under his leadership, that division grew to an over $1 billion consulting services business. In addition, Nackel has served as managing director of New Ventures, Ernst & Young's venture capital fund, and as CEO of Sogeti North America, the professional services division of Capgemini. "Ingenix Consulting has the health care market's deepest collection of expertise and results-oriented analytic capabilities, all focused on finding the best, practical solutions to the problems facing clients and the industry at large," said Nackel. "Ingenix Consulting is filled with passionate, brilliant professionals dedicated to improving the quality of life for millions of people, whether developing new drugs and medical devices, providing care to patients or supporting the industry with information and technologies. I am excited to join and lead this business." About Ingenix Consulting Ingenix Consulting, a data-driven organization in health and human services, employs more than 1,000 consultants with experience working with hospitals, physicians, health plans, government agencies and life sciences companies. Ingenix Consulting is a division of Ingenix. For more information, visit www.ingenixconsulting.com. About Ingenix Ingenix, a UnitedHealth Group (NYSE: UNH | Quote | Chart | News | PowerRating) company, is a leading provider of health information, technologies and consulting services. Organizations rely on its innovative products, services and consulting to improve the delivery and operations of their business. More information about Ingenix can be obtained at www.ingenix.com. SOURCE: Ingenix Ingenix Kyle Christensen, 952-833-7446 kyle.christensen@ingenix.com For full details on UnitedHealth Group Inc. (UNH) click here. UnitedHealth Group Inc. (UNH) has Short Term PowerRatings of 4. Details on UnitedHealth Group Inc. (UNH) Short Term PowerRatings is available at This Link.
Email Print Archives Feedback Email Article Link
Close X
Related News [UNH]
UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday December 3 12:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.
The TradingMarkets Directory
Stocks
Options
Forex
E-mini/Futures
How to Trade
Tools
PowerRatings
Blogs
Premium Subscription Services
RELATED SITES
Please call 1-213-955-5858 ext. 1
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice. It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN. The Connors Group, Inc. © Copyright 2009 The Connors Group, Inc. All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy. © 2009 The Connors Group, Inc.
|
